$4.23
+0.15 (+3.68%)
Open$4.11
Previous Close$4.08
Day High$4.29
Day Low$4.11
52W High$23.20
52W Low$3.67
Volume—
Avg Volume3.74M
Market Cap536.64M
P/E Ratio—
EPS$-1.06
SectorPharmaceuticals
Analyst Ratings
Hold
17 analysts
Price Target
+900.5% upside
Current
$4.23
$4.23
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.11B | 980.37M | 180.40M |
| Net Income | -147,474,697 | -117,002,139 | 49.45M |
| Profit Margin | -13.3% | -12.6% | 27.4% |
| EBITDA | -52,781,132 | -44,201,406 | 94.91M |
| Free Cash Flow | — | — | 60.57M |
| Rev Growth | +13.4% | +13.4% | -1.4% |
| Debt/Equity | 0.22 | 0.22 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |